Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.68
Delayed Data
As of Dec 09
 -0.08 / -10.53%
Today’s Change
0.61
Today|||52-Week Range
1.71
-51.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.0K--1.0K--
 
 
 
 
Operating ExpensesGross Income-2.0K0.00-1.0K0.00
 
 
 
General Expenses743.9K602.5K471.1K305.4K
 
 
 
 
 
Research And Development333.9K233.2K123.6K35.6K
 
 
 
 
 
Total Operating Expenses745.9K602.5K472.1K305.4K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-745.9K-602.5K-472.1K-305.4K
 
 
 
 
 
Extraordinary Charge-1.6M0.000.00--
 
 
Other Expenses212.6K-2.0K-11.1K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.1M-577.5K-483.2K-291.1K
 
 
 
 
 
Discontinued Operations-229.6K0.000.00--
 
 
Net Income-2.4M-577.5K-483.2K-291.1K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.7M13.7M13.7M--
 
 
 
 
Shares To Calculate EPS Diluted13.7M13.7M13.7M--
 
 
 
 
 
Earnings Per ShareEPS---$0.04-$0.04-$0.02
 
 
 
 
EPS Diluted-$0.18-$0.04-$0.04-$0.02